greeksoup/ stock research

Superior Group of Companies, Inc.: Q4 FY2025 earnings call

What management said about Q4 FY2025, from the documents filed with the SEC on 3 March 2026: press release. Guidance figures: 2 new. The quarter’s numbers.

Key takeaways

  • Fourth-quarter net sales increased: Net sales were $146.6 million against $145.4 million a year earlier. Management said revenue grew while expenses were reduced. Source
  • Net income and EPS both rose: Net income was $3.5 million, or $0.23 per diluted share, against $2.1 million, or $0.13. Pretax income was $4.1 million against $2.5 million. Source
  • EBITDA rose to $8.6 million: EBITDA was $8.6 million against $7.3 million a year earlier. The CEO linked the 19% year-over-year EBITDA growth to lower expenses alongside higher revenue. Source
  • Full-year net income declined: Full-year 2025 net income was $7.0 million, or $0.46 per diluted share, against $12.0 million, or $0.73 in 2024. Net sales were $566.2 million against $565.7 million. Source
  • Healthcare Apparel EBITDA fell: Healthcare Apparel net sales were $28.8 million against $30.3 million, and segment EBITDA was $0.6 million against $1.1 million. Contact Centers EBITDA was $2.5 million against $3.0 million. Source
  • Operating cash flow fell: Net cash provided by operating activities was $19.7 million for full-year 2025 against $33.4 million in 2024. Source
  • 2026 forecast introduced: Management said the 2026 forecast reflects further anticipated growth in both revenue and EPS. Source

“We finished the year with a solid fourth quarter, growing our consolidated revenues while simultaneously reducing expenses which resulted in 19% year-over-year EBITDA growth and earnings per share that nearly doubled,”

Michael Benstock, Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Net sales Sourcefull-year 2026$572 million to $585 millionNew
Diluted EPS Sourcefull-year 2026$0.54 to $0.66New

What changed from last quarter

  • New guidance: Company introduced a full-year 2026 net sales forecast of $572 million to $585 million. Source
  • New guidance: Company introduced a full-year 2026 diluted EPS forecast of $0.54 to $0.66. Source

Fourth quarter and full-year results

  • Fourth-quarter net sales increased: Net sales were $146.6 million against $145.4 million a year earlier. Management said revenue grew while expenses were reduced. Source
  • Net income and EPS both rose: Net income was $3.5 million, or $0.23 per diluted share, against $2.1 million, or $0.13. Pretax income was $4.1 million against $2.5 million. Source
  • EBITDA rose to $8.6 million: EBITDA was $8.6 million against $7.3 million a year earlier. The CEO linked the 19% year-over-year EBITDA growth to lower expenses alongside higher revenue. Source
  • Full-year net income declined: Full-year 2025 net income was $7.0 million, or $0.46 per diluted share, against $12.0 million, or $0.73 in 2024. Net sales were $566.2 million against $565.7 million. Source

Segment performance

  • Branded Products sales rose: Branded Products net sales were $96.9 million against $92.4 million, with segment EBITDA of $11.0 million against $8.9 million. Source
  • Healthcare Apparel EBITDA fell: Healthcare Apparel net sales were $28.8 million against $30.3 million, and segment EBITDA was $0.6 million against $1.1 million. Contact Centers EBITDA was $2.5 million against $3.0 million. Source
  • Full-year segment sales mix: Full-year 2025 net sales were $361.1 million for Branded Products, $115.9 million for Healthcare Apparel and $92.5 million for Contact Centers, against $353.3 million, $119.2 million and $96.9 million in 2024. Source

“This year we plan to expand our growing new business pipelines by capturing market share across our three attractive end markets with quality, innovative solutions, while leveraging our efficiencies and diverse supply base to further expand margins.”

Michael Benstock, Chief Executive Officer

Costs and margins

  • Selling and admin expenses declined: Selling and administrative expenses were $48.6 million in the fourth quarter against $50.0 million, and $199.5 million for full-year 2025 against $199.9 million. Source
  • Cost of goods sold increased: Cost of goods sold was $92.6 million in the fourth quarter against $91.4 million. For full-year 2025 it was $353.3 million against $345.1 million. Source
  • Full-year gross margin declined: Full-year 2025 gross margin was $212.9 million against $220.6 million in 2024, with Branded Products gross margin at $123.7 million. Source
  • EBITDA margin moved in opposite directions: EBITDA margin was 5.9% in the fourth quarter against 5.0%, and 4.5% for full-year 2025 against 6.0% for 2024. Source

Cash flow and balance sheet

  • Operating cash flow fell: Net cash provided by operating activities was $19.7 million for full-year 2025 against $33.4 million in 2024. Source
  • Receivables absorbed cash: Accounts receivable used $10.8 million of cash in 2025, against an $8.0 million source in 2024. Source
  • Capital spending was lower: Additions to property, plant and equipment were $3.9 million in 2025 against $4.4 million in 2024. Source
  • Revolver borrowings increased: Borrowings under the revolving lines of credit were $95.0 million in 2025, against $47.0 million, with repayments of $82.0 million against $50.0 million. Source
  • Year-end cash higher: Cash and cash equivalents were $23.7 million at year end against $18.8 million a year earlier. Long-term debt was $87.1 million against $80.4 million. Source

“Enabled by our strong balance sheet, returning capital to shareholders through our attractive dividend even while investing for future growth remains a pillar of our strategy in our quest to further enhance long-term shareholder value.”

Michael Benstock, Chief Executive Officer

Shareholder returns and dividend

  • Share repurchases rose: Common shares repurchased and retired cost $10.1 million in 2025 against $7.4 million. Shares outstanding were 15,730,615 at year end, against 16,484,921. Source
  • Dividend payments declined: Payments of cash dividends were $8.9 million in 2025 against $9.3 million in 2024. Source
  • Quarterly dividend held at $0.14: Cash dividends per common share were $0.14 in the fourth quarter of both years, and $0.56 for each full year. Source

Strategy, growth and 2026 plans

  • Back-end weighted results: Management described the business as back-end weighted, with 6% sequential top-line growth and EPS up 28% from the third quarter. Source
  • Three segments serve large markets: The company describes its three segments as each serving large, fragmented and growing addressable markets. Source
  • Organic growth plus acquisitions: The company says it is committed to enhancing shareholder value through organic growth and strategic acquisitions. Source
  • 2026 forecast introduced: Management said the 2026 forecast reflects further anticipated growth in both revenue and EPS. Source

Risks management discussed

  • External: Management described the period as uncertain and tied cost containment to moving through it. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.